Categories AlphaGraphs, Earnings, Health Care
MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal 2023. The company’s net loss widened from the prior-year quarter.
Revenues decreased 31% from last year to $2.25 million in the second quarter. The decline mainly reflects weak performance by the Integra subsidiary.
Net loss attributable to Trxade Health was $1.97 million or $2.90 per share in Q2, compared to a loss of $1.08 million or $1.99 per share in the same period of last year.
The TRxADE platform increased its registered users by 1,149 or 8% as of June 30, 2023, compared to June 30, 2022. For the six months ended June 30, new registrations were 291, compared to 339 a year earlier. At the end of the quarter, the company had total registered users of around 4,100+, compared to 12,962 last year.
Prior Performance
Most Popular
PNC Earnings: A snapshot of PNC Financial Services’ Q4 2025 results
PNC Financial Services Group, Inc. (NYSE: PNC) on Friday reported higher revenue and net income for the fourth quarter of fiscal 2025. The numbers also beat analysts' estimates. Total revenues
Earnings Preview: Intuitive Surgical (ISRG) looks poised for a strong Q4
Intuitive Surgical, Inc. (NASDAQ: ISRG) is a pioneer in robotic-assisted surgical technology, developing advanced systems that enable healthcare professionals to perform minimally invasive procedures with greater precision and efficiency. Having
What to expect when Alaska Air Group (ALK) reports Q4 2025 earnings results
Shares of Alaska Air Group (NYSE: ALK) gained 3% on Thursday. The stock has dropped 26% in the past 12 months. The airline is scheduled to publish its earnings results
